Suspected improper accounting for purchased-component inventories at Chinese consolidated subsidiaries and resulting inventory write-down

An issue in which the accounting treatment for purchased-component inventories at 2 Chinese consolidated subsidiaries was found to be potentially non-compliant with internal rules, resulting in an inventory write-down being recognized in the interim period. No prior-period financial statements were restated; the matter was accounted for in FY2025.